Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marin Viđak

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Journal of Medical Internet Research|August 31, 2022
Publishing Identifiable Patient Photographs in Scientific Journals: Scoping Review of Policies and PracticesMarija Roguljić, Dina Šimunović, Tina Poklepović Peričić, et al.
Journal of Cardiovascular Development and Disease|June 26, 2024
Heart Failure with Mid-Range or Mildly Reduced Ejection Fraction in the Era of Sodium-Glucose Co-Transporter 2 Inhibitors: Do We Now Provide Better Care for the "Middle Child of HF"? Real-World Experience from a Single Clinical CentreMarin Viđak, Jelena Kursar, Tomislava Bodrožić Džakić Poljak, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Journal of Medical Internet Research|August 31, 2022
Publishing Identifiable Patient Photographs in Scientific Journals: Scoping Review of Policies and PracticesMarija Roguljić, Dina Šimunović, Tina Poklepović Peričić, et al.
Journal of Cardiovascular Development and Disease|June 26, 2024
Heart Failure with Mid-Range or Mildly Reduced Ejection Fraction in the Era of Sodium-Glucose Co-Transporter 2 Inhibitors: Do We Now Provide Better Care for the "Middle Child of HF"? Real-World Experience from a Single Clinical CentreMarin Viđak, Jelena Kursar, Tomislava Bodrožić Džakić Poljak, et al.
Pageof 3